Executive Change: Mirion (NYSE: MIR) Appoints Shelia Webb as President Nuclear Medicine
Oak Ridge, TN – Mirion has announced the appointment of Shelia Webb as President Nuclear Medicine. About Mirion: Mirion (NYSE: MIR) is a global leader in radiation safety, science, and medicine, providing solutions for radiation detection, measurement, analysis, and monitoring across diverse end markets. The company empowers innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation. Mirion Technologies group focuses on nuclear and safety, advancing nuclear energy through proven radiation safety technologies and expertise. Meanwhile, the Mirion Medical group is dedicated to improving quality in cancer care with solutions that enhance delivery and ensure safety in the medical landscape. Headquartered in Atlanta, Georgia, USA, Mirion employs approximately 3,200 people and operates in 12 countries. The company plays a critical role in advancing innovation and supporting safety and reliability in highly regulated environments, with solutions deployed in over 98% of the world’s nuclear power plants and more than 6,000 cancer centers globally.
For more information on Mirion please visit: https://www.mirion.com/
Mirion
107 Union Valley Rd
Oak Ridge, TN 37830
Phone: 800-243-3955
LinkedIn Page: https://www.linkedin.com/company/mirion/
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved